Rare Disease Laboratories, Daiichi Sankyo Co., Ltd., Tokyo 140-8710, Japan.
Translational Research Department, Daiichi Sankyo RD Novare Co., Ltd., Tokyo 134-8630, Japan.
Cell Chem Biol. 2019 Jan 17;26(1):137-143.e8. doi: 10.1016/j.chembiol.2018.10.012. Epub 2018 Nov 15.
Molecular target identification of small molecules, so-called target deconvolution, is a major obstacle to phenotype-based drug discovery. Here, we developed an approach called perturbation-based proteomic correlation profiling (PPCP) utilizing the correlation between protein quantity and binding activity of compounds under cellular perturbation by gene silencing and successfully identified lanosterol synthase as a molecular target of TGF-β pathway inhibitor. This PPCP concept was extended to the use of a cell line panel and provides a new option for target deconvolution.
小分子的分子靶标鉴定,即所谓的靶标剖析,是基于表型的药物发现的主要障碍。在这里,我们开发了一种称为基于扰动的蛋白质组相关分析(PPCP)的方法,利用基因沉默引起的细胞扰动下化合物的蛋白含量与结合活性之间的相关性,并成功地将羊毛甾醇合酶鉴定为 TGF-β 途径抑制剂的分子靶标。这个 PPCP 概念被扩展到细胞系面板的使用,并为靶标剖析提供了新的选择。